Navigation Links
OrthAlign, Inc. Announces European Distribution Agreement with Lima Corporate for Award-Winning KneeAlign® Total Knee Arthroplasty Technology

OrthAlign, Inc., a privately held U.S.-based medical device company, announced today that it has entered into a European distribution agreement with Lima Corporate, for its award-winning Total Knee Arthroplasty (TKA) technology, KneeAlign®.

KneeAlign provides both tibial and distal femoral precision alignment in a simple, palm-sized, single-use device, providing real-time data. It is highly accurate for overall mechanical, tibial, and femoral component alignment in TKA, providing a reliable and efficient alternative to expensive Computer Assisted Surgery (CAS) systems, logistically arduous patient-specific cutting blocks, and invasive conventional methods used with an intramedullary rod. To date, KneeAlign has successfully been used in over 30,000 TKA cases, throughout the world.

“As Lima embarked on building a best-in-class platform to provide surgeons with a complete range of solutions in TKA, we were convinced that OrthAlign’s precision alignment technology should be included in our offering,” said Luigi Ferrari, Lima Corporate’s Chief Executive Officer. “OrthAlign deserves credit for its game-changing technology and we are looking forward to working together.”

Dr. André Ferreira (French orthopedic surgeon, Clinique du Parc, Lyon, France) states, “I’m very excited that OrthAlign technology will now be fully-integrated into Lima’s portfolio. KneeAlign is efficient because it provides accurate information about tibial slope and flexion-extension of the femur, which we did not have so accessible before. Varus-Valgus alignment is also beneficial because, previously, we only did valgus estimation of the femur with x-rays. KneeAlign is like CAS, but all of the data and the accuracy are now in the palm of my hand.”

In a published TKA clinical study by Denis Nam, M.D. (Washington University, St. Louis, MO), significant differences favoring the use of KneeAlign vs. CAS were found with regard to the accuracy of femoral component alignment, with 94.9% of patients in the KneeAlign cohort having an alignment within 2° of neutral vs. 92.5% in the CAS cohort. There was also a significant difference in overall mechanical alignment of the limb, with 92.5% of patients within 3° of neutral mechanical axis in the KneeAlign cohort vs. 86.3% in the CAS cohort.

In another TKA study by Dr. Nam (conducted as a randomized controlled trial, consisting of five different surgeons), it was found that KneeAlign® decreases the incidence of outliers for tibial component alignment in both the coronal and sagittal planes, and improves the surgeon’s ability to achieve a specific, intraoperative goal, compared to conventional, tibial extramedullary (EM) alignment guides in TKA. In the KneeAlign cohort, 95.7% of tibial components were within 2° of perpendicular to the tibial mechanical axis and 95% of tibial components were within 2° of a 3° posterior slope (compared to 68.1% and 72.1% in the EM cohort, respectively).

“We are pleased to partner with Lima in further expanding our award-winning KneeAlign technology to surgeons and patients throughout the European continent,” said William E. Maya, OrthAlign’s Chief Executive Officer. “There were approximately 540,000 TKAs in Europe during 2014 and this number will likely increase as the population ages, so this is a very important market for us in our international growth strategy. Lima’s forward-thinking vision in providing surgeons with a best-in-class platform of technologies resonated with us and we are honored to be a key part of the offering. Ultimately, we hope it helps to raise the standard of care throughout Europe for TKAs”.

The distribution agreement covers the European Economic Area (EEA) and Switzerland markets, excluding Romania.

About OrthAlign, Inc.

OrthAlign is a privately held medical device and technology company, committed to providing orthopedic surgeons with cutting edge, user-friendly, surgical navigation products for precise alignment and positioning. We believe that our technology will raise the standard of care in Total Knee and Total Hip Arthroplasty surgeries by making consistent and measurable results accessible to all surgeons, hospitals, and patients. Our strategy is to leverage this technology to provide simple and precision-driven solutions for a broad range of orthopedic procedures. For more information regarding OrthAlign, please visit

About Lima Corporate

Lima Corporate is a global medical device company providing reconstructive orthopaedic solutions to surgeons who face the challenges of improving the quality of life of their patients. Based in Italy, Lima Corporate is committed to the development of innovative products and procedures to enable surgeons to select ideal solutions for every individual patient. Lima Corporate’s product range includes large joint revision and primary implants and complete extremities solutions, including fixation. For additional information on the Company, please visit        

“ORTHALIGN®, ORTHALIGN PLUS®, KNEEALIGN®, and KNEEALIGN® 2 are [registered] trademarks of OrthAlign, Inc.”

Read the full story at

Source: PRWeb
Copyright©2015 Vocus, Inc.
All rights reserved

Related medicine news :

1. OrthAlign, Inc. Announces U.S. Commercial Launch of ORTHALIGN PLUS®, the most complete handheld navigation device for use in Total Hip Arthroplasty Surgery
2. OrthAlign, Inc. Announces That Its Board of Directors Has Appointed Gary D. Henley as Executive Chairman
3. OrthAlign, Inc. Announces Milestone in 13,500th KneeAlign® Total Knee Arthroplasty Case
4. OrthAlign, Inc. announces US FDA clears ORTHALIGN PLUS™, the first handheld navigation device for use with both Total Hip and Total Knee Arthroplasty Surgeries
5. ATP Announces Agreement with Micron for Legacy (SDR/DDR) DRAM Module Support
6. The Atlanta Institute for Facial Aesthetic Surgery Announces August 18 “Back-to-School” Event
7. Catalent Biologics Announces New Advisory Board
8. 3WON Announces Appointment of New Director
9. Employee Fiduciary Announces Subsidiary
10. NOVA Pride Announces Theme for the 2015 Northern Virginia Pride Festival
11. As The Navy Changes Body-Fat Rules, the World Patent Marketing Review Team Announces the Development of the Assisted Dumbbell Bench Rack
Post Your Comments:
(Date:7/1/2020)... ... July 01, 2020 , ... The Society ... Professor of Medicine at the University of Massachusetts Medical School- Baystate and Ann ... joined the SIDM Board of Directors. Dr. Salvador and Ms. Gaffey’s service began ...
(Date:6/28/2020)... ... June 26, 2020 , ... ... to provide high-quality, intensive education and training that prepares graduates for professional careers ... new member of the Board of Trustees. , Ms. Williams currently serves as ...
(Date:6/28/2020)... ... 26, 2020 , ... The Coronavirus pandemic created shortages in ... supplier of top-quality masks, sanitizers and thermometers, Trusted PPE is a woman and ... observed, “All of our masks are manufactured to medical standards in FDA-certified factories, ...
(Date:6/28/2020)... ... June 28, 2020 , ... ... world, dedicates World Allergy Week, from June 28 to July 4, 2020, to ... CoV-2. , COVID-19, short for “coronavirus disease 2019”, is a disease spreading around ...
(Date:6/24/2020)... BEACH, Calif. (PRWEB) , ... June 24, 2020 , ... ... it has launched a new website at The newly launched website ... of broad-spectrum CBD oils , and a comprehensive line of skincare & ...
Breaking Medicine News(10 mins):
(Date:6/23/2020)... ... June 23, 2020 , ... Construction at the ... now features a greatly enlarged and enhanced medical facility. Penetron crystalline technology ... tanks, and rooftop garden. , Part of the Bangkok Chain Hospital (BCH) network ...
(Date:6/19/2020)... ... June 19, 2020 , ... The Covid-19 pandemic has had ... Establishing a safe environment and compliant workforce is critical in the post-Covid world. , ... its popular SupplyBay vending machine below cost for a limited time only. , ...
(Date:6/19/2020)... NEW YORK (PRWEB) , ... ... ... announces the launch of its cross-platform campaign 'Clinical Trials.' This campaign showcases ... who participate in these studies, thereby advancing knowledge and disease treatment. This ...
Breaking Medicine Technology: